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1. Introduction 
In [ 1,2] the target of the novel antibiotic, pseudo- 
manic acid A (fig.l), in the bacterial cell, was shown 
to be isoleucyl-tRNA synthetase (IRS). The antibiotic 
is a powerful competitive inhibitor, with respect to 
isoleucine, of the Escherichia coli B enzyme (table 1). 
It specifically inhibits the formation of the IRS . iso- 
leucyl adenylate complex, as measured by the pyro- 
phosphate exchange reaction (Ki 6 X low9 M; cf. Km 
6.3 X 10” M; pH 7.4,37’C) [3]. The binding ratio of 
sodium pseudomonate A to IRS is -1: 1. The result- 
ing sodium pseudomonate A . IRS complex is stable 
and can be isolated by gel filtration on Sephadex 
G-50. The aminoacylation of yeast tRNA1le, catalysed 
by rat liver IRS, is also competitively inhibited, with 
respect to isoleucine, by sodium pseudomonate A [3] 
but the Ki (20 X lo6 M) is several orders of mag- 
nitude higher than that observed for the E. coli 
B enzyme (table 1). It has been suggested [3,4] that 
the epoxide sidechain terminus of the antibiotic, 
which has the same carbon skeleton as isoleucine, 
competes for the amino acid binding site on the 
enzyme. 
The antibiotic has a narrow range of antimicrobial 
activity which is generally confined to Gram positive 
bacteria [ 51. Most Gram negative organisms, having 
less penetrable cell walls, are highly resistant to the 
antibiotic [e.g., minimum inhibitory concentration 
(MIC) against Pseudomonas aeroginosa, X00 gg/ml; 
cf. MIC against Staphylococcus aureus, 0.1 pg/ml]. 
With the discovery of the target of pseudomonic 
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acid in the bacterial cell, the question arises of how 
the producing organism of the antibiotic Pseudomo- 
nas fluorescens (NUB 10586) [ 81, is able to survive 
the fermentation, since the antibiotic is released in 
the fermentation broth at relatively high levels for a 
substantial period of the replication phase of the 
organism [6,7]. There is some evidence from studies 
with cell wall-deficient mutants of E. coli that the 
significantly greater MIC value for the wild type 
organism (cf. cell wall mutants) is due, at least in 
part, to the antibiotics reduced ability to penetrate 
the cell wall [2]. It is not known, however, to what 
extent reduced cell wall permeability or structural 
alteration of the Ps. fluorescens enzyme contributes 
to the relative insensitivity of the organism to the 
antibiotic. 
Table 1 
Source of IRS Kinetic constantsa 
(overall aminoacylation) 
Km Ki 
Ps. fluorescens 
NCIB 10586 9.1 X 1O-6 M 14.5 X 1O-3 M 
E. coli B 11.1 X lo+ Mb,c 2.5 X 1O-9 Mb 
Rat liver 5.4 X lo+ Mb 2 X 10+Mb 
apH 7.5, 37°C; bfrom [3];CKm=4.6 X 10T6 M from[9-131 
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(pH 7.8); 5 mM ATP, 70 mM KCl, 10 mM MgCl*, 
0.5 mM EDTA, 250 i.tg bulk tRNA and L-[Ui4C]- 
isoleucine (l-14 PM). After incubation for 20 min 
at 37°C the reaction was quenched with 7% trichloro- 
acetic acid (1.5 ml) and left at O&C for 30 min. 
The sample was filtered through a Whatman GFjC 
glass fibre filter, which was washed successively with 
7% trichloroacetic acid (5 X 2 ml) and absolute tha- 
nol (3 X 5 ml). The filters were dried at 100°C for 
10 mm and radiocounted. 
2.5. Steady state inhibitory kinetics of Ps. fluorescens 
isoleucyl tRNA synthetase 
The rate of isoleucyl-t~A1le formation was fol- 
lowed by the above a~noacylation assay at various 
[“‘Clisoleucine (1-7 PM) and sodium pseudomon- 
ate A (O-l 5 mM) concentrations. Each experiment 
was carried out in triplicate and in each case the reac- 
tion rate was shown to be linear for a20 min. The 
results are shown in fig.2. 
3. Discussion 
As demonstrated for the E. coli B and rat liver 
isoleucyl-tea synthetases, the enzyme from the 
pseudomonic acid A producing organism, Ps. &ores- 
tens NCIB 10586, was competitively inhibited by 
sodium pseudomonate, with respect to isoleucine. It 
had been established that it is the formation of the 
IRS e ILE - AMP complex catalysed by the E. cob 
B isoleucyl-tRNA synthetase and not the transfer of 
Ile from the complex to tRNA1le that is competi- 
tively inhibited with respect to isoleucine [3]. For the 
overall aminoacylation reaction, the Michaelis con- 
stants for IRS from the 3 sources (table 1) are of the 
same order of magnitude. However, the inhibitory 
constants (Ki) differ signi~cantly . The Ki for the 
E. co& B enzyme is 4000-toes lower than the Kr,, 
indicating the great aftkity of sodium pseudomon- 
ate A for the enzyme, whilst the K, and Ki for the 
rat liver enzyme are the same order of magnitude. 
The latter observation clearly indicates that the euca- 
ryotic enzyme has less aftinity for the antibiotic than 
the E. coli B enzyme, which is probably the major 
reason for the low toxicity of the drug in mammals 
[5]. The Ki for the Ps. fluorescens IRS, however, is 
1600~times greater than the 1y,, and 6 X 106-fold 
greater than the Ki for the E. coli B enzyme, clearly 
indicating that the enzyme from the antibiotic pro- 
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ducing organism has a much poorer affinity for the 
antibiotic. It appears therefore that the Ps. j7uorw 
tens enzyme is structur~ly altered compared with 
IRS from E. coli B and the producing organism of the 
antibiotic avoids uicide, at least in part, by produc- 
ing a pseudomonic acid-resistant isoleucyl-tRNA syn- 
thetase. The extent to which penetration of the anti- 
biotic through the cell wall from the medium, permit- 
ting reentry of pseudomonic acid into the cell during 
the fermentation, isrestricted (and thereby contribut. 
ing to the ability of the organism to overcome the 
inhibitory effects of the antibiotic), is not known. 
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